Insider · CIK 0001439716
Mary E. Godwin
Files at NAUT (Nautilus Biotechnology, Inc.). First filing Sep 18, 2024, latest Sep 25, 2024.
In brief
Mary E. Godwin files SEC Form 4 as officer at NAUT (Nautilus Biotechnology, Inc.). Since Sep 18, 2024, Mary E. Godwin has reported 0 open-market buys worth $0 and 2 open-market sells worth $235k, the latest filed on Sep 25, 2024.
A track record needs three past buys with six months of prices behind them; Mary E. Godwin has 0, so none is measured yet.
The newest scored trade: sold $135k of NAUT on Sep 23, 2024, filed Sep 25, 2024, scored 31 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NAUT: Nautilus Biotechnology, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 31Weak | NAUTsell Nautilus Biotechnology, Inc. | $135k 47,031 shares | -100% | +25% from low-18% from high | |
| 30Weak | NAUTsell Nautilus Biotechnology, Inc. | $100k 35,000 shares | -100% | +31% from low-18% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 17, 2024 | NAUT NAUTILUS BIOTECHNOLOGY INC | 38,337 0.03% of outstanding | $74k | Dec 17, 2024 | $873k |
| Dec 9, 2024 | NAUT NAUTILUS BIOTECHNOLOGY, INC. | 35,000 0.03% of outstanding | $75k | Dec 9, 2024 | $898k |
| Dec 3, 2024 | NAUT NAUTILUS BIOTECHNOLOGY, INC. | 60,000 0.05% of outstanding | $132k | Dec 3, 2024 | $766k |
| Nov 26, 2024 | NAUT NAUTILUS BIOTECHNOLOGY, INC. | 60,000 0.05% of outstanding | $137k | Nov 26, 2024 | $630k |
| Nov 21, 2024 | NAUT NAUTILUS BIOTECHNOLOGY INC | 30,000 0.02% of outstanding | $71k | Nov 21, 2024 | $559k |
| Nov 19, 2024 | NAUT NAUTILUS BIOTECHNOLOGY, INC. | 30,000 0.02% of outstanding | $68k | Nov 19, 2024 | $491k |
| Nov 12, 2024 | NAUT NAUTILUS BIOTECHNOLOGY INC | 40,000 0.03% of outstanding | $99k | Nov 11, 2024 | $491k |
| Nov 8, 2024 | NAUT NAUTILUS BIOTECHNOLOGY INC | 31,078 0.02% of outstanding | $78k | Nov 8, 2024 | $314k |
| Nov 7, 2024 | NAUT NAUTILUS BIOTECHNOLOGY, INC. | 28,922 0.02% of outstanding | $80k | Nov 7, 2024 | $235k |
| Sep 23, 2024 | NAUT NAUTILUS BIOTECHNOLOGY, INC. | 47,031 0.04% of outstanding | $135k | Sep 23, 2024 | $100k |
| Sep 17, 2024 | NAUT NAUTILUS BIOTECHNOLOGY, INC. | 35,000 0.03% of outstanding | $100k | Sep 17, 2024 | none |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 23, 2024 | NAUT Nautilus Biotechnology, Inc. | MOption exercise Common Stock | +47,031 | $0.46 | $22k | 47,031 | Sep 25, 2024 |
| Sep 23, 2024 | NAUT Nautilus Biotechnology, Inc. | SOpen-market sale Common Stock | -47,031 | $2.87 | $135k | 0 | Sep 25, 2024 |
| Sep 23, 2024 | NAUT Nautilus Biotechnology, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -47,031 | $0.00 | $0 | 353,337 | Sep 25, 2024 |
| Sep 17, 2024 | NAUT Nautilus Biotechnology, Inc. | MOption exercise Common Stock | +35,000 | $0.46 | $16k | 35,000 | Sep 18, 2024 |
| Sep 17, 2024 | NAUT Nautilus Biotechnology, Inc. | SOpen-market sale Common Stock | -35,000 | $2.85 | $100k | 0 | Sep 18, 2024 |
| Sep 17, 2024 | NAUT Nautilus Biotechnology, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -35,000 | $0.00 | $0 | 400,368 | Sep 18, 2024 |
| Mar 1, 2024 | NAUT Nautilus Biotechnology, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +160,000 | $0.00 | $0 | 160,000 | Mar 5, 2024 |
Questions about Mary E. Godwin
Answered from the filings on this page, as of the latest one.
Is Mary E. Godwin buying or selling?
Not in the last 12 months. Mary E. Godwin's latest open-market trade on SEC Form 4 was sold $135k of NAUT on Sep 23, 2024.
How did Mary E. Godwin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mary E. Godwin has 0.
Where does Mary E. Godwin file Form 4?
Mary E. Godwin has filed Form 4 at NAUT (Nautilus Biotechnology, Inc.) as Senior VP, Operations. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.